Skip to main content
BioLineRx Ltd. (TLV:BLRX)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1.000
0.00 (0.00%)
Nov 12, 2026, 4:09 PM IST

BioLineRx Ratios and Metrics

Millions ILS. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
304286415100309
Market Cap Growth
-42.80%-51.17%-79.39%314.57%-67.59%60.58%
Enterprise Value
23-487367-65126
Last Close Price
0.010.020.060.380.140.43

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-14.4514.4514.4514.4514.45
PS Ratio
7.2011.100.8124.01--
PB Ratio
0.600.561.758.720.561.46
P/TBV Ratio
-7.177.80-0.982.14

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
5.56-0.8321.22--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.480.441.120.880.240.07
Net Debt / Equity Ratio
-0.31-0.46-0.34-2.37-0.76-0.77
Net Debt / EBITDA Ratio
0.421.070.300.761.362.18
Net Debt / FCF Ratio
0.471.320.101.381.472.22
Asset Turnover
0.040.030.560.07--
Inventory Turnover
0.110.093.63---
Quick Ratio
1.011.761.521.024.855.89
Current Ratio
1.201.951.761.104.875.91
Return on Equity (ROE)
-55.27%-11.01%-69.11%-189.23%-41.96%-60.04%
Return on Assets (ROA)
-19.82%-16.11%-23.28%-38.30%-23.10%-24.07%
Return on Capital Employed (ROCE)
-61.50%-35.70%-81.50%-203.40%-44.40%-34.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-78.56%-8.97%-39.26%-52.59%-87.63%-27.24%
FCF Yield
-108.00%-61.81%-187.02%-19.72%-92.62%-23.83%
Buyback Yield / Dilution
-49.34%-105.76%-24.37%-24.47%-16.75%-162.19%